ARTICLE | Distillery Therapeutics
Neurology
November 15, 2017 7:22 PM UTC
Mouse studies suggest activating RAB26 could help treat motor neuron diseases involving PLEKHG5 mutations, such as distal spinal muscular atrophy type IV, Charcot-Marie-Tooth disease and amyotrophic l...